1 not yet recruiting, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Not yet recruiting 1, Terminated 1 |
Follow Pemphigus: new trials by email Literature Review of Pemphigus trials Research Report on Pemphigus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab With Corticosteroids Versus Corticosteroids Plus Azathioprine for Moderate-to-Severe Pemphigus Vulgaris Rituxan (rituximab), Azathioprine (AZA)' plus corticosteroids - Pemphigus Vulgaris, Rituximab (RTx) | Early Phase 1 | Not yet recruiting | Khyber Teaching Hospital | 92 | 2026-12-02 | 2026-08-18 |
| Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus Sirolimus (formerly known as Rapamycin) - Pemphigus | Early Phase 1 | Terminated | University of California, Irvine | 3 | 2011-02-01 | 2017-06-09 |
Autoimmune Diseases (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Vesiculobullous (2) · Skin and Connective Tissue Diseases (2)
Adrenal Cortex Hormones (1) · Azathioprine (1) · Rituximab (1) · Sirolimus (1)
Khyber Teaching Hospital (1) · University of California, Irvine (1)
United States (1)